McKesson (MEX:MCK) Long-Term Debt: MXN94,834 Mil (As of Mar. 2026)


MEX:MCK McKesson Corp MEX:MCK
75 GF Score
Price MXN14,083.59
GF Value MXN14,286.09
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is McKesson Long-Term Debt?

McKesson MEX:MCK 75 Long-Term Debt is MXN94,834 Mil as of Mar. 2026. GuruFocus rates MEX:MCK with a GF Score™ of 75/100 and a GF Value™ of MXN14,286.09 (Fairly Valued). The stock has 2 warning signs investors should review.

McKesson's Long-Term Debt for the quarter that ended in Mar. 2026 was MXN94,834 Mil.

McKesson's quarterly Long-Term Debt declined from Sep. 2025 (MXN110,267 Mil) to Dec. 2025 (MXN97,681 Mil) and declined from Dec. 2025 (MXN97,681 Mil) to Mar. 2026 (MXN94,834 Mil).

McKesson's annual Long-Term Debt declined from Mar. 2024 (MXN92,591 Mil) to Mar. 2025 (MXN91,305 Mil) but then increased from Mar. 2025 (MXN91,305 Mil) to Mar. 2026 (MXN94,834 Mil).


McKesson  (MEX:MCK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


McKesson Long-Term Debt Related Terms


McKesson Long-Term Debt Historical Data

* Premium members only.

The historical data trend for McKesson's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

McKesson Long-Term Debt Chart

McKesson Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101,147.88 83,383.65 92,590.51 91,304.95 94,833.97

McKesson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91,304.95 122,917.02 110,266.99 97,680.92 94,833.97
MEX:MCK
75GF Score
McKesson Corp MEX:MCK
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of MXN94,834 Mil mean?
McKesson (MEX:MCK) has a Long-Term Debt of MXN94,834 Mil as of Mar. 2026.
Is McKesson's Long-Term Debt too high?
McKesson's current Long-Term Debt is MXN94,834 Mil. Overall, McKesson has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's Long-Term Debt compare to CAH and COR?
McKesson's Long-Term Debt of MXN94,834 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. McKesson's current Long-Term Debt is MXN94,834 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (MEX:MCK) is currently considered Fairly Valued. The stock's GF Value™ is MXN14,286.09, compared to a current price of MXN14,083.59 — trading 1.4% below its estimated fair value. The current Long-Term Debt is MXN94,834 Mil. McKesson's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For McKesson (MEX:MCK), the current Long-Term Debt is MXN94,834 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is McKesson (MEX:MCK) Overvalued in 2026?

Based on GuruFocus' analysis, McKesson stock appears to be undervalued. The current stock price of MXN14,083.59 is trading 1.4% below its estimated GF Value™ of MXN14,286.09. GuruFocus considers McKesson to be Fairly Valued.

Key valuation signals for MEX:MCK:

  • Long-Term Debt: MXN94,834 Mil
  • GF Value™: MXN14,286.09 vs. price of MXN14,083.59 (1.4% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the MEX:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


McKesson Business Description

Address 6555 State Highway 161, Irving, TX, USA, 75039
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
75GF Score

Get the complete analysis for MEX:MCK

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN14,083.59
Price
MXN14,286.09
GF Value